Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Disease Models & Mechanisms|September 28, 2014
Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophyInès Barthélémy, Fernanda Pinto-Mariz, Erica Yada, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2007
Lack of myostatin results in excessive muscle growth but impaired force generationHelge Amthor, Raymond Macharia, Roberto Navarrete, et al.
The American Journal of Pathology|January 27, 2004
Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophiesSusan C Brown, Silvia Torelli, Martin Brockington, et al.
Annals of Neurology|February 27, 2010
Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutationHans Knoblauch, Christian Geier, Stephanie Adams, et al.
Human Gene Therapy|June 25, 2013
Gene correction of a duchenne muscular dystrophy mutation by meganuclease-enhanced exon knock-inLinda Popplewell, Taeyoung Koo, Xavier Leclerc, et al.
Biochemical and Biophysical Research Communications|March 9, 2002
Deficiency of alpha-dystroglycan in muscle-eye-brain diseaseHiroki Kano, Kazuhiro Kobayashi, Ralf Herrmann, et al.
Annals of Neurology|July 12, 2002
Periaxin mutations cause a broad spectrum of demyelinating neuropathiesHiroshi Takashima, Cornelius F Boerkoel, Peter De Jonghe, et al.
Neuromuscular Disorders : NMD|October 13, 2012
Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositisJulia V Wanschitz, Odile Dubourg, Emmanuelle Lacene, et al.
Clinical Biochemistry|July 10, 2003
Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagentsWenli Zhang, Jiri Vajsar, Pinjiang Cao, et al.
Pageof 16